Navigation Links
OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival
Date:4/22/2008

PORTLAND, Ore. An Oregon Health & Science University Cancer Institute researcher has identified a protein that is a strong indicator of survival for men with advanced prostate cancer. The C-reactive protein, also known as CRP, is a special type of protein produced by the liver that is elevated in the presence of inflammation.

"This could mean that a simple blood test that is already available could help in clinical decision making and patient counseling. Patients and doctors would know better what to expect from the prostate cancer they are facing," said Tomasz Beer, M.D., director of the Prostate Cancer Research Program at the OHSU Cancer Institute, associate professor of medicine (hematology/medical oncology), OHSU School of Medicine.

Beer's research will be published online in the journal Cancer on Monday, April 21.

Past research has shown that cancer causes an inflammatory response. This research also suggests that inflammation may play an important role in driving prostate cancer progression and resistance to therapy. Inflammatory cells are attracted to cancer sites and this local inflammation can lead to a release of inflammatory markers, like CRP.

"While inflammation may sometimes slow the progression of the cancer, an increasing body of evidence suggests that cancer can actually take advantage of the inflammatory response, and the reaction of the immune system may fuel cancer progression. To the extent that our hypothesis proves true, C-reactive protein may be reflecting the overall intensity of the inflammation," Beer said.

The finding that higher CRP is associated with shorter survival and a lower probability of response to chemotherapy is a result of a secondary analysis of inflammatory markers in patients enrolled in the ASCENT study, a large Phase 2 clinical trial that evaluated treatment with docetaxel and DN-101, a high dose formulation of calcitriol or docetaxel with placebo. This analysis include
'/>"/>

Contact: Christine Decker
deckerch@ohsu.edu
503-494-8231
Oregon Health & Science University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Phone counseling improves quality of life, immune systems of cervical cancer survivors
2. Prostate cancer screening program leads to bigger fall in death rates than surrounding areas
3. A stem cell type supposed to be crucial for angiogenesis and cancer growth does not exist?
4. Potential viral therapy weapon for difficult cancers is safe and effective in study
5. American Cancer Society report details cancer prevention efforts
6. Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation
7. Cancer cells spread by releasing bubbles, according to an MUHC study
8. Thousands of volunteers needed to help bring cure for cancer closer
9. Many Cancer Survivors Are Overweight and Sedentary: Study
10. Study reveals inaccuracies in studies of cancer treatment
11. Cancer survivors have low levels of physical activity and high levels of obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Hearing aids are not always covered ... holders to determine what their hearing care benefits are. ... health plans and has published benefit details on their website ... , The following is a list of insurances or agencies ... NYSHIP/ NYS Empire Plan - Hearing Aid Benefit is $1500 ...
(Date:8/26/2014)... August 27, 2014 Emerging and established ... and useful to those they serve – which includes ... blog at http://www.PerWickstrom.com and read his latest ... Leaders Maintain their Edge.” , “Leadership is ... and can therefore be assumed,” commented Per Wickstrom, who ...
(Date:8/26/2014)... August 27, 2014 There are a ... however the reality is cruel. Some people, especially ladies ... may not save enough money to be affluent. Today, ... delighted to announce its new catalog, Flash Deals (also ... bags, outdoor accessories and more from this company are ...
(Date:8/26/2014)... 27, 2014 Atlanta Hearing Associates ... Hearing Associates has expanded its professional staff to 6 audiologists. ... Stephanie Collins . Atlanta Hearing Associates prides itself ... display a passionate commitment to patient needs and keep themselves ... loss treatments. The practice has grown from 1 to 4 ...
(Date:8/26/2014)... (PRWEB) August 27, 2014 Private ... custom labeled nutritional dietary supplements and products has ... their 33rd annual Inc. 500|5000 list. This exclusive ... marks the second consecutive year for Private Label ... Dell, Yelp, GoPro, Bridger, Tough Mudder, Bowlmor and ...
Breaking Medicine News(10 mins):Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 3Health News:Per Wickstrom’s Latest Blog Post Provides 10 Tips to Help Leaders Maintain their Edge 2Health News:Become a Rich Person Right Away By Taking Advantage Of Fecbek.com's Flash Deals 2Health News:Atlanta Hearing Associates Needs New Audiologists to Its Professional Staff 2Health News:Atlanta Hearing Associates Needs New Audiologists to Its Professional Staff 3Health News:Private Label Nutraceuticals Honored by Inc. 5000 as One of Today’s Fastest Growing Private Companies in America with Three-Year Sales Growth of 620% 2Health News:Private Label Nutraceuticals Honored by Inc. 5000 as One of Today’s Fastest Growing Private Companies in America with Three-Year Sales Growth of 620% 3Health News:Private Label Nutraceuticals Honored by Inc. 5000 as One of Today’s Fastest Growing Private Companies in America with Three-Year Sales Growth of 620% 4
... N.C. The addition of a chemotherapeutic drug for leukemia ... to enhance the response of certain ovarian cancers to treatment, ... Duke Comprehensive Cancer Center. , "We know that a ... types of cancers, including some ovarian cancers," said Deanna Teoh, ...
... 18 "Getting closer to controlling cancer" requires funding ... of the new federal stimulus, say former White House ... Washington University Medical Center breast cancer laboratory director, ... Denver Post. Weiner, Berg, and former government analyst Paulette ...
... Awareness Month , , SATURDAY, April 18 (HealthDay News) -- ... 200 sites across the United States in May, which ... and children with symptoms such as wheezing, coughing and ... the screenings that will be conducted by allergists. , ...
... (Nasdaq: ISTA ), today announced it will release first ... a conference call to discuss these results and provide a pipeline ... Date: Thursday, May 7, 2009, Time: 5:00 ... Internet: www.istavision.com, Domestic dial-in: 866-356-3377, ...
... PTU can cause liver disease, experts say , , FRIDAY, April ... of the antithyroid drug (PTU) in children has been endorsed ... editor in the April 9 New England Journal of ... liver disease in children and should no longer be used ...
... Perspective HARRISBURG, Pa., April 17 Agriculture ... the first meeting of the Governor,s Food Safety Council on ... The council will meet from 1 p.m. to 4 p.m. ... Harrisburg Area Community College . The council will hear a ...
Cached Medicine News:Health News:Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers 2Health News:Getting Closer to Controlling Cancer Requires Funding More Laboratories and Commitment Beyond Two Years of New Stimulus, Weiner and Berg Assert in Denver Post Oped 2Health News:Group Urges Public to Take Free Asthma Tests in May 2Health News:Drug May Be Dangerous for Kids With Graves' Disease 2Health News:Pennsylvania Governor's Food Safety Council to Hold First Meeting on April 22 2
(Date:8/26/2014)... DIEGO , Aug. 26, 2014 Profil ... research organization (CRO) focused on diabetes and obesity, announced ... completion of more than 200 phase I – IIa ... the treatment of type 1 and type 2 diabetes. ... of research is what it represents for the public ...
(Date:8/26/2014)... , Aug. 26, 2014  Ruthigen Inc. (NASDAQ: ... on improving patient outcomes and reducing healthcare costs ... drug candidate, RUT58-60, has received a recommendation from ... patients in the Company,s planned Phase 1/2 clinical ... as an adjunct therapy in combination with prophylactic ...
(Date:8/26/2014)...   Organovo Holdings, Inc. (NYSE MKT: ONVO) ... 3D bioprinting technology, announced today that it has been recognized ... World Economic Forum (WEF) .  Organovo is one ... creativity to design and create transformative solutions. ... Pioneer by the World Economic Forum for the innovation ...
Breaking Medicine Technology:Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes 2Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes 3Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60 2Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60 3Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60 4Organovo Named 2015 Technology Pioneer by World Economic Forum 2Organovo Named 2015 Technology Pioneer by World Economic Forum 3
... Primary Endpoint, with Positive Effect Sustained Through ... Duration of 4-Week ... VNDA ) (Vanda) today announced positive top-line results from,a Phase III ... agonist, met the primary endpoint,of the trial and significantly improved sleep ...
... with initiatives aimed at knowledge transfer, including landmark ... Massachusetts and the Italian government in ... an innovator and,leader in global patient recruitment for clinical ... of initiatives to make its,quarter-century of expertise more accessible ...
Cached Medicine Technology:Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 2Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 3Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 4Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 5Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 6Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 7Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 8Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 9BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 2BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 3BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 4
Determination of Prothrombin Time (PT)by STA Analyzers (ISI~1.8).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
The CA method used on the Dade Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of calcium in serum....
The PHOS method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of phosphorus in serum....
For the quantitative in vitro determination of Magnesium in serum, plasma and urine...
Medicine Products: